The exclusion criteria were: females who were pregnant or experiencing a menstrual period, type 2 diabetes treated using an insulin regimen, malignancy, hematopathy, active tuberculosis, peptic ulcer with gastric bleeding, binge-eating disorder, psychiatric disease, congestive heart failure, clinically relevant renal or hepatic insufficiency, unstable coronary artery disease, cancer or a history of cancer
Diabetes Care (2019) 42(9):173341
In many cases, the exact injection site matters less than proper administration and consistency
But Penn Medicine's research shows that inconsistent use of some GLP-1 weight-loss medications may significantly reduce their effectiveness
The results showed that Sag induced significant apoptosis in the Daudi, Raji, and Jurkat cells, while having little to no effect on Hut-78 cells or normal BT lymphocytes
Conclusin Los frmacos GLP-1 estn transformando el panorama del tratamiento de la obesidad y la diabetes